(NVT) nVent Electric - Overview
Stock: Enclosures, Connections, Cable-Management, Cooling, Fastening
| Risk 5d forecast | |
|---|---|
| Volatility | 36.6% |
| Relative Tail Risk | -8.16% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.35 |
| Alpha | 49.98 |
| Character TTM | |
|---|---|
| Beta | 1.503 |
| Beta Downside | 1.388 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.67% |
| CAGR/Max DD | 0.79 |
EPS (Earnings per Share)
Revenue
Description: NVT nVent Electric January 02, 2026
nVent Electric plc (NYSE:NVT) designs, manufactures, markets, installs, and services electrical connection and protection solutions worldwide, operating through two segments: Enclosures, which safeguard electronics in mission-critical settings such as data centers, and Electrical & Fastening Solutions, which deliver power and data infrastructure components including cable management, cooling, and testing tools. Its product portfolio is sold via distributors, retailers, contractors, and OEMs under brands like CADDY, ERICO, HOFFMAN, ILSCO, SCHROFF, and TRACHTE, serving industrial, commercial, residential, infrastructure, and energy markets.
Key recent metrics: FY 2023 revenue reached approximately $2.3 billion, up ~8 % YoY, driven largely by a 12 % surge in data-center enclosure sales; adjusted EBITDA margin held steady near 12 %; and free cash flow generated $250 million, supporting a 2024 share-repurchase program. Primary economic drivers include accelerating global data-center construction (projected CAGR ≈ 7 % through 2027) and the ongoing electrification of renewable-energy infrastructure, which boosts demand for robust power-distribution and protection products. The broader Electrical Components & Equipment sector benefits from rising industrial automation spend and stricter safety regulations, both of which favor nVent’s diversified solution set.
For a deeper, data-rich assessment of nVent’s valuation and competitive positioning, consider exploring the analyst tools available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 710.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -3.02 > 1.0 |
| NWC/Revenue: 16.34% < 20% (prev 19.55%; Δ -3.21% < -1%) |
| CFO/TA 0.07 > 3% & CFO 465.2m > Net Income 710.3m |
| Net Debt (1.32b) to EBITDA (832.8m): 1.59 < 3 |
| Current Ratio: 1.63 > 1.5 & < 3 |
| Outstanding Shares: last quarter (164.0m) vs 12m ago -2.50% < -2% |
| Gross Margin: 37.74% > 18% (prev 0.40%; Δ 3733 % > 0.5%) |
| Asset Turnover: 57.31% > 50% (prev 44.63%; Δ 12.67% > 0%) |
| Interest Coverage Ratio: 8.33 > 6 (EBITDA TTM 832.8m / Interest Expense TTM 75.0m) |
Altman Z'' 3.24
| A: 0.09 (Total Current Assets 1.64b - Total Current Liabilities 1.00b) / Total Assets 6.85b |
| B: 0.23 (Retained Earnings 1.60b / Total Assets 6.85b) |
| C: 0.09 (EBIT TTM 625.0m / Avg Total Assets 6.79b) |
| D: 1.19 (Book Value of Equity 3.73b / Total Liabilities 3.12b) |
| Altman-Z'' Score: 3.24 = A |
Beneish M -2.73
| DSRI: 1.01 (Receivables 693.0m/528.0m, Revenue 3.89b/3.01b) |
| GMI: 1.07 (GM 37.74% / 40.22%) |
| AQI: 0.96 (AQ_t 0.70 / AQ_t-1 0.73) |
| SGI: 1.30 (Revenue 3.89b / 3.01b) |
| TATA: 0.04 (NI 710.3m - CFO 465.2m) / TA 6.85b) |
| Beneish M-Score: -2.73 (Cap -4..+1) = A |
What is the price of NVT shares?
Over the past week, the price has changed by +0.54%, over one month by +6.40%, over three months by +7.12% and over the past year by +69.89%.
Is NVT a buy, sell or hold?
- StrongBuy: 8
- Buy: 4
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the NVT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 127 | 12.1% |
| Analysts Target Price | 127 | 12.1% |
| ValueRay Target Price | 160.5 | 41.7% |
NVT Fundamental Data Overview February 12, 2026
P/E Forward = 27.3973
P/S = 4.6732
P/B = 4.8773
P/EG = 1.7585
Revenue TTM = 3.89b USD
EBIT TTM = 625.0m USD
EBITDA TTM = 832.8m USD
Long Term Debt = 1.55b USD (from longTermDebt, last quarter)
Short Term Debt = 13.8m USD (from shortTermDebt, last quarter)
Debt = 1.56b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.32b USD (from netDebt column, last quarter)
Enterprise Value = 19.52b USD (18.19b + Debt 1.56b - CCE 237.5m)
Interest Coverage Ratio = 8.33 (Ebit TTM 625.0m / Interest Expense TTM 75.0m)
EV/FCF = 52.48x (Enterprise Value 19.52b / FCF TTM 371.9m)
FCF Yield = 1.91% (FCF TTM 371.9m / Enterprise Value 19.52b)
FCF Margin = 9.55% (FCF TTM 371.9m / Revenue TTM 3.89b)
Net Margin = 18.25% (Net Income TTM 710.3m / Revenue TTM 3.89b)
Gross Margin = 37.74% ((Revenue TTM 3.89b - Cost of Revenue TTM 2.42b) / Revenue TTM)
Gross Margin QoQ = 36.46% (prev 37.45%)
Tobins Q-Ratio = 2.85 (Enterprise Value 19.52b / Total Assets 6.85b)
Interest Expense / Debt = 1.22% (Interest Expense 19.1m / Debt 1.56b)
Taxrate = 25.91% (40.5m / 156.3m)
NOPAT = 463.1m (EBIT 625.0m * (1 - 25.91%))
Current Ratio = 1.63 (Total Current Assets 1.64b / Total Current Liabilities 1.00b)
Debt / Equity = 0.42 (Debt 1.56b / totalStockholderEquity, last quarter 3.73b)
Debt / EBITDA = 1.59 (Net Debt 1.32b / EBITDA 832.8m)
Debt / FCF = 3.56 (Net Debt 1.32b / FCF TTM 371.9m)
Total Stockholder Equity = 3.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.46% (Net Income 710.3m / Total Assets 6.85b)
RoE = 19.60% (Net Income TTM 710.3m / Total Stockholder Equity 3.62b)
RoCE = 12.09% (EBIT 625.0m / Capital Employed (Equity 3.62b + L.T.Debt 1.55b))
RoIC = 8.74% (NOPAT 463.1m / Invested Capital 5.30b)
WACC = 10.62% (E(18.19b)/V(19.75b) * Re(11.45%) + D(1.56b)/V(19.75b) * Rd(1.22%) * (1-Tc(0.26)))
Discount Rate = 11.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.29%
[DCF Debug] Terminal Value 73.24% ; FCFF base≈450.8m ; Y1≈556.1m ; Y5≈947.0m
Fair Price DCF = 56.32 (EV 10.41b - Net Debt 1.32b = Equity 9.09b / Shares 161.4m; r=10.62% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 66.15 | EPS CAGR: 16.97% | SUE: 0.0 | # QB: 0
Revenue Correlation: 75.74 | Revenue CAGR: 12.12% | SUE: 0.79 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.93 | Chg30d=+0.003 | Revisions Net=+1 | Analysts=12
EPS current Year (2026-12-31): EPS=4.14 | Chg30d=+0.077 | Revisions Net=+2 | Growth EPS=+23.6% | Growth Revenue=+17.2%
EPS next Year (2027-12-31): EPS=4.81 | Chg30d=+0.130 | Revisions Net=+1 | Growth EPS=+16.2% | Growth Revenue=+8.2%